000 01384 a2200385 4500
005 20250515221907.0
264 0 _c20100611
008 201006s 0 0 eng d
022 _a1539-2864
024 7 _a10.1097/iae.0b013e3181d34a8c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeng, Theodore
245 0 0 _aFocal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_cApr 2010
300 _aS66-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarboplatin
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aInjections
650 0 4 _aLaser Coagulation
650 0 4 _aLasers, Semiconductor
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aRetinal Neoplasms
_xdrug therapy
650 0 4 _aRetinoblastoma
_xdrug therapy
650 0 4 _aRetinoblastoma Protein
_xgenetics
700 1 _aCebulla, Colleen M
700 1 _aSchefler, Amy C
700 1 _aMurray, Timothy G
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 30
_gno. 4 Suppl
_gp. S66-8
856 4 0 _uhttps://doi.org/10.1097/iae.0b013e3181d34a8c
_zAvailable from publisher's website
999 _c19776954
_d19776954